Finance

Lists
603387:SHA
Getein Biotech Inc
CNยฅ8.26
+0.73%
(+0.060) 1D
Nov 17, 3:00:00โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603387...
Open
CNยฅ8.17
High
CNยฅ8.30
Low
CNยฅ8.10
Mkt. cap
4.16B
Avg. vol.
8.47M
Volume
5.58M
Dividend
3.63%
Quarterly dividend
CNยฅ0.08
Ex-dividend date
Sep 18, 2026
P/E ratio
14.32
52-wk high
CNยฅ11.42
52-wk low
CNยฅ7.37
EPS
CNยฅ0.58
Shares outstanding
186.01M
No. of employees
2K
Open
CNยฅ8.17
High
CNยฅ8.30
Low
CNยฅ8.10
Mkt. cap
4.16B
Avg. vol.
8.47M
Volume
5.58M
Dividend
3.63%
Quarterly dividend
CNยฅ0.08
Ex-dividend date
Sep 18, 2026
P/E ratio
14.32
52-wk high
CNยฅ11.42
52-wk low
CNยฅ7.37
EPS
CNยฅ0.58
Shares outstanding
186.01M
No. of employees
2K
News stories
From web sources and news partners
About Getein Biotech Inc
CEO-
Employees1.73K
FoundedMar 8, 2002
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
294.03M
267.50M
287.83M
264.82M
Cost of goods sold
104.16M
79.33M
98.45M
75.25M
Cost of revenue
104.16M
79.33M
98.45M
75.25M
Research and development expenses
31.00M
41.35M
41.44M
44.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
70.47M
70.85M
79.39M
88.75M
Operating expense
101.95M
112.82M
133.89M
121.00M
Total operating expenses
206.11M
192.15M
232.34M
196.25M
Operating income
87.92M
75.35M
55.49M
68.57M
Other non operating income
6.42M
-2.79M
1.63M
-9.28M
EBT including unusual items
64.52M
80.89M
123.85M
52.63M
EBT excluding unusual items
83.86M
77.67M
105.73M
68.40M
Income tax expense
2.79M
7.65M
13.35M
5.56M
Effective tax rate
4.33%
9.45%
10.78%
10.57%
Other operating expenses
5.52M
-7.71M
11.97M
-8.74M
Net income
60.12M
76.30M
107.99M
48.11M
Net profit margin
20.45%
28.52%
37.52%
18.17%
Earnings per share
-
-
-
-
Interest and investment income
-
7.58M
55.96M
5.00M
Interest expense
-3.42M
-2.46M
-1.70M
-1.55M
Net interest expenses
-3.42M
5.12M
54.26M
3.45M
Depreciation and amortization charges
-
-
-
-
EBITDA
108.45M
95.88M
77.48M
89.11M
Gain or loss from assets sale
47.74K
-
-181.14K
181.14K
Upcoming events
AI content may include mistakes. Learn more
Google apps